Trials Sponsors Conditions Drugs Pricing

Conditions

Cardiovascular Diseases CKD Sarcopenia

Outcome Measures

Primary Outcomes (2)

Epicardial adipose tissue measured by ultrasound color doppler
EAT is defined as a fat depot that exists on the surface of the myocardium,which plays a detrimental role in our health. EAT would be measured by ultrasound color doppler.
the day when being recruited
Intima-media thickness measured by ultrasound color doppler
IMT of carotid arteries, as assessed noninvasively by carotid ultrasonography, is a useful measure of preclinical atherosclerosis. Carotid IMT has been found to predict future risk of cardiovascular disease.IMT would be measured by ultrasound color doppler.
the day when being recruited

Secondary Outcomes (1)

Baseline demographic, clinical and laboratory characteristics
the day when being recruited

Study Arms (2)

sarcopenia

CKD patients with sarcopenia, meeting the following two criteria (1) male LTI (lean tissue index)\< 7.0 kg/m2, female LTI \< 5.7 kg/m2; (2) Male HGS)(handgrip strength \< 26 kg, female HGS \< 18 kg.

non-sarcopenia

CKD patients with non-sarcopenia

Eligibility Criteria

Age18 Years - 75 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

patients with chronic kidney disease

You may qualify if:

Patients presented by the Nephrology Center during August 2019 and March 2021

Sponsors & Collaborators

Shanghai Jiao Tong University School of Medicine
Otherlead

Study Sites (1)

Baoshan Site of Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, 200001, China

MeSH Terms

Conditions

SarcopeniaCardiovascular Diseases

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

Jiangzi Yuan, MD
Baoshan Site of Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University
STUDY DIRECTOR

Enrollment

120 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: OTHER
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Associate Chief Physician of Nephrology

Study Record Dates

First Submitted

July 27, 2022

First Posted

July 29, 2022

Study Start

January 1, 2020

Actual (reported)

The Relationship Between Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease and the Risk Involved.

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (2)

sarcopenia

non-sarcopenia

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (1)

Study Arms (2)

sarcopenia

non-sarcopenia

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations